Document is current
Any future updates will be listed below
-
Authors
Li, Tianyu
Lin, Chen
Wang, Weibin
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82173074)
Beijing Natural Science Foundation (7232127)
National High Level Hospital Clinical Research Funding (No.2022-PUMCH-D-001, No. 2022-PUMCH-B-004)
CAMS Innovation Fund for Medical Sciences (2021-I2M-1-002)
Non-profit Central Research Institute Fund of Chinese Academy of Medical Science (2018PT32014)
- License Information
-
More Information
Article History
Received: 2 September 2024
Accepted: 24 January 2025
First Online: 3 February 2025
Declarations
:
: The Global Burden of Disease (GBD) study is conducted under the guidelines of the Institute for Health Metrics and Evaluation (IHME) and complies with the Declaration of Helsinki. The data utilized in this study were obtained from publicly available, de-identified datasets, which do not require individual participant consent. The IHME ensures all ethical considerations are addressed, and the use of de-identified health data is approved by their institutional review board. Therefore, separate ethics approval and consent to participate were not required for this secondary data analysis.
: Not applicable.
: The authors declare no competing interests.
